TrialAnnals of hematology2022

Sequential eradication of Helicobacter pylori as a treatment for immune thrombocytopenia in patients with moderate thrombocytopenia: a multicenter prospective randomized phase 3 study.

Boram Han et al.PubMed ↗Publisher ↗

No numbers read from the abstract.